EMPAGLIFLOZIN | EMPAGLIFLOZIN | ATC A10BX12 ATC A10BD19 ATC A10BK03 ATC A10BD20
METABOLISM TREATMENT OF TYPE 2 DIABETES MELLITUS SODIUM-GLUCOSE CO-TRANSPORTER2 (SGLT2) INHIBITOR | ORAL | Cmax 687 NANOMOLAR Tmax 1.5 HOUR VD 73.8 LITER PPB 86.2 PERCENT Cl 10.6 LITER / HOUR HT 12.4 HOUR SOLUBILITY VERY SLIGHTLY SOLUBLE IN WATER | SODIUM-GLUCOSE CO-TRANSPORTER2 (SGLT2) | SODIUM/GLUCOSE COTRANSPORTER 2 INHIBITOR CHEMBL3884 SODIUM/GLUCOSE COTRANSPORTER 2 P31639 SODIUM/GLUCOSE COTRANSPORTER 2 HOMO SAPIENS TRANSPORTER ELECTROCHEMICAL SLC SLC05 | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |